Underrepresentation of Older Adults in Clinical Trials of Chimeric Antigen Receptor (CAR) T-Cell Therapy for Hematologic Malignancies: An FDA Analysis

被引：0
|
作者：
Seam, Pamela [1 ]
Mahat, Upendra [2 ]
Bouchkouj, Najat [2 ]
Sharma, Poornima [2 ]
Peredo-Pinto, Helka [2 ]
Elmacken, Mona [2 ]
Kaushal, Megha [2 ]
Jia, Yuxia [2 ]
Wang, Shu [3 ]
Xu, Zhiheng [3 ]
Kasamon, Yvette [1 ]
Kanaparu, Bindu [1 ]
Richardson, Nicholas [1 ]
Gormley, Nicole [1 ]
机构：
[1] US FDA, Div Hematol Malignancies 2, Ctr Drug Evaluat & Res CDER, Silver Spring, MD USA
[2] US FDA, Div Clin Evaluat Hematol, Ctr Biol Evaluat & Res CBER, Off Therapeut Prod OTP, Silver Spring, MD USA
[3] US FDA, Ctr Drug Evaluat & Res CDER, Off Biostat, Silver Spring, MD USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-186544
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Underrepresentation of Racial and Ethnic Minorities in Registrational Chimeric Antigen Receptor (CAR) T-Cell Therapy Trials in Hematologic Malignancies: An FDA Analysis
    Mahat, Upendra
    Seam, Pamela
    Bouchkouj, Najat
    Sharma, Poornima
    Peredo-Pinto, Helka
    Elmacken, Mona
    Kaushal, Megha
    Wang, Shu
    Xu, Zhiheng
    Jia, Yuxia
    Richardson, Nicholas
    Kanapuru, Bindu
    Kasamon, Yvette
    Gormley, Nicole
    BLOOD, 2023, 142
  • [2] Chimeric Antigen Receptor (CAR) T-Cell Therapy in Hematologic Malignancies: Clinical Implications and Limitations
    Bluem, Philipp
    Kayser, Sabine
    CANCERS, 2024, 16 (08)
  • [3] Characterizing inclusion and exclusion criteria in clinical trials for chimeric antigen receptor (CAR) T-cell therapy among adults with hematologic malignancies
    Jaggers, Jordon L.
    Giri, Smith
    Klepin, Heidi D.
    Wildes, Tanya M.
    Olin, Rebecca L.
    Artz, Andrew
    Wall, Sarah
    Jaglowski, Samantha
    William, Basem
    Benson, Don M.
    Rosko, Ashley E.
    JOURNAL OF GERIATRIC ONCOLOGY, 2021, 12 (02) : 235 - 238
  • [4] Infections after chimeric antigen receptor (CAR)-T-cell therapy for hematologic malignancies
    Kampouri, Eleftheria
    Little, Jessica S.
    Rejeski, Kai
    Manuel, Oriol
    Hammond, Sarah P.
    Hill, Joshua A.
    TRANSPLANT INFECTIOUS DISEASE, 2023, 25
  • [5] Infections after chimeric antigen receptor (CAR)-T-cell therapy for hematologic malignancies
    Kampouri, Eleftheria
    Little, Jessica S.
    Rejeski, Kai
    Manuel, Oriol
    Hammond, Sarah P.
    Hill, Joshua A.
    TRANSPLANT INFECTIOUS DISEASE, 2023, 25
  • [6] Chimeric Antigen Receptor T-cell Therapy to Target Hematologic Malignancies
    Kenderian, Saad Sirop
    Ruella, Marco
    Gill, Saar
    Kalos, Michael
    CANCER RESEARCH, 2014, 74 (22) : 6383 - 6389
  • [7] Chimeric Antigen Receptor (CAR) T-Cell Therapy for Thoracic Malignancies
    Kiesgen, Stefan
    Chicaybam, Leonardo
    Chintala, Navin K.
    Adusumilli, Prasad S.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (01) : 16 - 26
  • [8] Chimeric Antigen Receptor T-Cell Therapy for Hematologic Malignancies: A Practical Review
    Strati, Paolo
    Gregory, Tara
    Majhail, Navneet S.
    Jain, Nitin
    JCO ONCOLOGY PRACTICE, 2023, 19 (09) : 706 - +
  • [9] Chimeric Antigen Receptor T-cell Therapy Current Status and Clinical Outcomes in Pediatric Hematologic Malignancies
    Talleur, Aimee C.
    Myers, Regina
    Annesley, Colleen
    Shalabi, Haneen
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2022, 36 (04) : 701 - 727
  • [10] Chimeric antigen receptor T-cell therapy in hematologic malignancies: Successes, challenges, and opportunities
    Ho, Matthew
    Zanwar, Saurabh
    Paludo, Jonas
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 112 (02) : 197 - 210
12345